# Treatment of Resistant Hypertension by Renal Denervation in China

> **NCT02027012** · NA · TERMINATED · sponsor: **Boston Scientific Corporation** · enrollment: 1 (actual)

## Conditions studied

- Medication-resistant Hypertension

## Interventions

- **DEVICE:** Percutaneous renal denervation with the Vessix™ Renal Denervation System

## Key facts

- **NCT ID:** NCT02027012
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-09
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** company strategic change
- **Last updated:** 2020-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02027012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02027012, "Treatment of Resistant Hypertension by Renal Denervation in China". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT02027012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*